PHILADELPHIA, PA — Passage Bio, Inc. (Nasdaq: PASG) this week reported its third quarter financial results for 2024, ...

Shares of Avidity Biosciences surged to a record high Wednesday after the company showed its hand in the cardiovascular space ...

GSK is the fifth company to leave BIO in roughly a year, a group that includes Pfizer and UCB. The departures coincided with ...

Vivek Ramaswamy has withdrawn from the Ohio Senate race to support Trump's initiative with Elon Musk on government efficiency ...

GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...

On Oct. 15, Modifi Bio, a Yale-based biotech company, closed an acquisition deal with Merck, an American pharmaceutical ...

The company ended the quarter with $192 million in cash and equivalents, enough to fund operations past 2027. 2seventy Bio ...

MEMS, wearable/implantable electronics and bio-tissue therapeutics, the pursuit of piezoelectric biomaterials has become a ...

Austin Butler’s height has become a hot topic since he portrayed the King of Rock and Roll, Elvis Presley, in Elvis. How tall ...

Binance Labs has invested in BIO Protocol, a pioneering protocol transforming the way early-stage scientific research is ...

Bio-based materials may pose a greater health risk to some of the planet's most important species than the conventional ...

Analysts estimate that bluebird bio will report an earnings per share (EPS) of $-0.37. Anticipation surrounds bluebird bio's announcement, with investors hoping to hear about both surpassing estimates ...